Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannes Alber

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
European Heart Journal|August 29, 2022
Empagliflozin in acute myocardial infarction: the EMMY trialDirk von Lewinski, Ewald Kolesnik, Norbert J Tripolt, et al.
Journal of Clinical Medicine|September 9, 2023
Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age RegistryWout W A van den Broek, Marieke E Gimbel, Dean R P P Chan Pin Yin, et al.
The Lancet. Respiratory Medicine|June 14, 2021
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trialAxel Bauer, Michael Schreinlechner, Nikolay Sappler, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
European Heart Journal|August 29, 2022
Empagliflozin in acute myocardial infarction: the EMMY trialDirk von Lewinski, Ewald Kolesnik, Norbert J Tripolt, et al.
Journal of Clinical Medicine|September 9, 2023
Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age RegistryWout W A van den Broek, Marieke E Gimbel, Dean R P P Chan Pin Yin, et al.
The Lancet. Respiratory Medicine|June 14, 2021
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trialAxel Bauer, Michael Schreinlechner, Nikolay Sappler, et al.
Pageof 5